相关实验视频
Updated: Jun 11, 2025

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
在因子VIIa的复杂的异质:触发触发器的触发
Jesper J Madsen1, Egon Persson2, Ole H Olsen3
1Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA; Center for Global Health and Infectious Diseases Research, Global and Planetary Health, College of Public Health, University of South Florida, Tampa, FL 33612, USA.
组织因子 (TF) 性激活因子VIIa (FVIIa),启动血液凝固. 对FVIIa全和工程变体的新见解为凝血过程提供了先进的控制.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 血液静止 血液静止 血液静止
背景情况:
- 因子VIIa (FVIIa) 启动血液凝固,这一过程严重依赖于其辅因子组织因子 (TF).
- TF充当FVIIa的膜结合性全激活剂,影响基质相互作用和下游凝血.
- 在FVIIa中,复杂的全性通路是由TF结合触发的,涉及复杂的分子相互作用.
研究的目的:
- 阐明TF对FVIIa的全激活机制.
- 调查TF在调节FVIIa活动和功能的作用.
- 探索工程FVIIa变体在治疗应用中的潜力.
主要方法:
- 对FVIIa和TF相互作用的生物化学研究.
- FVIIa变种的设计和特征.
- 在工程FVIIa构造的体内验证.
主要成果:
- 在FVIIa中,TF结合通过至少两个相互连接的通路诱导复杂质.
- 工程FVIIa变种表现出调制的特性和对TF诱导的全激活的反应.
- 抗体还可以调节FVIIa的活动,模仿或偏离TF介导作用.
- 工程 FVIIa 构造显示了 in vivo 的概念验证有益效应.
结论:
- 在了解和控制FVIIa全雌激素形成方面取得了重大进展.
- 了解FVIIa全性机制可以精确调节凝血.
- 未来的研究有望开发先进的FVIIa向疗法.
更多相关视频
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Clot Retraction and Fibrinolysis
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cooperative Allosteric Transitions

